Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins

Virology

Volumn 444, Issue 1-2, 2013, Pages 21-30

  Weir, Dawn L ^a   Smith, Ina L ^b   Bossart, Katharine N ^c   Wang, Lin Fa ^b,d   Broder, Christopher C ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b CSIRO   (Australia)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Australian bat lyssavirus; Emerging; Encephalitis; Envelope glycoprotein; Rabies virus; Receptor; Rhabdovirus; Tropism; Viral entry; Zoonosis

Indexed keywords

NERVE CELL ADHESION MOLECULE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; AUSTRALIAN BAT LYSSAVIRUS; CELL ADHESION; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; LIPID RAFT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RABIES VIRUS; VESICULAR STOMATITIS VIRUS; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

AUSTRALIAN BAT LYSSAVIRUS; EMERGING; ENCEPHALITIS; ENVELOPE GLYCOPROTEIN; RABIES VIRUS; RECEPTOR; RHABDOVIRUS; TROPISM; VIRAL ENTRY; ZOONOSIS;

ANIMALS; CHIROPTERA; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HORSES; HUMANS; LYSSAVIRUS; RHABDOVIRIDAE INFECTIONS; STAINING AND LABELING; VESICULOVIRUS; VIRAL ENVELOPE PROTEINS; VIRAL TROPISM; VIRUS INTERNALIZATION;

AUSTRALIAN BAT LYSSAVIRUS; EQUIDAE; LYSSAVIRUS; MAMMALIA; RABIES VIRUS; RHABDOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 84882907082     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.06.016     Document Type: Article

References (44)

1. Allworth A., Murray K., Morgan J. A human case of encephalitis due to a lyssavirus recently identified in fruit bats. Commun. Dis. Intellig 1996, 20:504.
2. Anonymous., 2013a. Australian Bat Lyssavirus-Australia (02): Queensland, Human Fatality. Pro-MED-mail, International Society for Infectious Diseases: March 21, Archive no. 20130323.1600266. Available at. http://www.promedmail.org.
3. Anonymous., 2013b. Australian Bat Lyssavirus-Australia (05): (Queensland) Equine, Fatal. Pro-MED-mail, International Society for Infectious Diseases: May 20, Archive no. 20130520.1724384. Available at. http://www.promedmail.org.
4. Baba M., Snoeck R., Pauwels R., de Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Chemother. 1988, 32:1742-1745.
5. Badrane H., Tordo N. Host switching in lyssavirus history from the Chiroptera to the carnivora orders. J. Virol. 2001, 75:8096-8104.
6. Blanco J.C., Pletneva L.M., Wieczorek L., Khetawat D., Stantchev T.S., Broder C.C., Polonis V.R., Prince G.A. Expression of human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection. Virol. J. 2009, 6:57.
7. Bonaparte M.I., Dimitrov A.S., Bossart K.N., Crameri G., Mungall B.A., Bishop K.A., Choudhry V., Dimitrov D.S., Wang L.F., Eaton B.T., Broder C.C. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:10652-10657.
8. Bossart K.N., Wang L.F., Eaton B.T., Broder C.C. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology 2001, 290:121-135.
9. Burrage T.G., Tignor G.H., Smith A.L. Rabies virus binding at neuromuscular junctions. Virus Res. 1985, 2:273-289.
10. Ceballos N.A., Moron S.V., Berciano J.M., Nicolas O., Lopez C.A., Juste J., Nevado C.R., Setien A.A., Echevarria J.E. Novel lyssavirus in bat, Spain. Emerg. Infect. Dis. 2013, 19:793-795.
11. Conti C., Superti F., Tsiang H. Membrane carbohydrate requirement for rabies virus binding to chicken embryo related cells. Intervirology 1986, 26:164-168.
12. Dube D., Schornberg K.L., Stantchev T.S., Bonaparte M.I., Delos S.E., Bouton A.H., Broder C.C., White J.M. Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection. J. Virol. 2008, 82:7238-7242.
13. Field H.E. Australian Bat Lyssavirus. School of Veterinary Science 2005, University of Queensland.
14. Fraser G.C., Hooper P.T., Lunt R.A., Gould A.R., Gleeson L.J., Hyatt A.D., Russell G.M., Kattenbelt J.A. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerg. Infect. Dis. 1996, 2:327-331.
15. Gaudin Y., Ruigrok R.W., Tuffereau C., Knossow M., Flamand A. Rabies virus glycoprotein is a trimer. Virology 1992, 187:627-632.
16. Gorfien S.F.U., Fike Richard M.(US), Dzimian Joyce L.(US), Godwin Glenn P.(US), Price Paul J.(US), Epstein David A.(US), Gruber Dale (US), Mcclure Don (US) Serum-free Mammalian Cell Culture Medium, and Uses Thereof 2004, Invitrogen Corp (US).
17. Gould A.R., Kattenbelt J.A., Gumley S.G., Lunt R.A. Characterisation of an Australian bat lyssavirus variant isolated from an insectivorous bat. Virus Res. 2002, 89:1-28.
18. Guyatt K.J., Twin J., Davis P., Holmes E.C., Smith G.A., Smith I.L., Mackenzie J.S., Young P.L. A molecular epidemiological study of Australian bat lyssavirus. J. Gen. Virol. 2003, 84:485-496.
19. Hanham C.A., Zhao F., Tignor G.H. Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor. J. Virol. 1993, 67:530-542.
20. Hanna J.N., Carney I.K., Smith G.A., Tannenberg A.E., Deverill J.E., Botha J.A., Serafin I.L., Harrower B.J., Fitzpatrick P.F., Searle J.W. Australian bat lyssavirus infection: a second human case, with a long incubation period. Med. J. Aust. 2000, 172:597-599.
21. Hooper P.T., Lunt R.A., Gould A.R., Samaratunga H., Hyatt A.D., Gleeson L.J., Rodwell B.J., Rupprecht C.E., Smith J.S., Murray P.K. A new lyssavirus: the first endemic rabies-related virus recognized in Australia. Bull. Inst. Pasteur 1997, 95:209-218.
22. Lawson N.D., Stillman E.A., Whitt M.A., Rose J.K. Recombinant vesicular stomatitis viruses from DNA. Proc. Nat. Acad. Sci. U.S.A. 1995, 92:4477-4481.
23. Lentz T.L., Burrage T.G., Smith A.L., Crick J., Tignor G.H. Is the acetylcholine receptor a rabies virus receptor?. Science 1982, 215:182-184.
24. Lentz T.L., Wilson P.T., Hawrot E., Speicher D.W. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 1984, 226:847-848.
25. Luscher-Mattli M., Gluck R., Kempf C., Zanoni-Grassi M. A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus. Arch. Virol. 1993, 130:317-326.
26. McCall B.J., Epstein J.H., Neill A.S., Heel K., Field H., Barrett J., Smith G.A., Selvey L.A., Rodwell B., Lunt R. Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999. Emerg. Infect. Dis. 2000, 6:259-264.
27. McCall B.J., Field H.E., Smith G.A., Storie G.J., Harrower B.J. Defining the risk of human exposure to Australian bat lyssavirus through potential non-bat animal infection. Commun. Dis. Intell. 2005, 29:202-205.
28. McColl K.A., Chamberlain T., Lunt R.A., Newberry K.M., Westbury H.A. Susceptibility of domestic dogs and cats to Australian bat lyssavirus (ABLV). Vet. Microbiol. 2007, 123:15-25.
29. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 1995, 57:521-546.
30. Morimoto K., Patel M., Corisdeo S., Hooper D.C., Fu Z.F., Rupprecht C.E., Koprowski H., Dietzschold B. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc. Nat. Acad. Sci. U.S.A. 1996, 93:5653-5658.
31. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
32. Popoff M.R., Poulain B. Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells. Toxins (Basel) 2010, 2:683-737.
33. Saeed M.F., Kolokoltsov A.A., Albrecht T., Davey R.A. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 2010, 6:e1001110.
34. Shah W.A., Peng H., Carbonetto S. Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via alpha-dystroglycan. J. Gen. Virol. 2006, 87:673-678.
35. Sieczkarski S.B., Whittaker G.R. Viral entry. Curr. Top Microbiol. Immunol. 2005, 285:1-23.
36. Superti F., Hauttecoeur B., Morelec M.J., Goldoni P., Bizzini B., Tsiang H. Involvement of gangliosides in rabies virus infection. J. Gen. Virol 1986, 67(Pt 1):47-56.
37. Sutter G., Ohlmann M., Erfle V. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 1995, 371:9-12.
38. Thoulouze M.I., Lafage M., Schachner M., Hartmann U., Cremer H., Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 1998, 72:7181-7190.
39. Tuffereau C., Benejean J., Blondel D., Kieffer B., Flamand A. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 1998, 17:7250-7259.
40. Tuffereau C., Desmezieres E., Benejean J., Jallet C., Flamand A., Tordo N., Perrin P. Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR. J. Gen. Virol 2001, 82:2861-2867.
41. Tuffereau C., Leblois H., Benejean J., Coulon P., Lafay F., Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989, 172:206-212.
42. Tuffereau C., Schmidt K., Langevin C., Lafay F., Dechant G., Koltzenburg M. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J. Virol. 2007, 81:13622-13630.
43. Vahlenkamp T.W., Verschoor E.J., Schuurman N.N., van Vliet A.L., Horzinek M.C., Egberink H.F., de Ronde A. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism. J. Virol. 1997, 71:7132-7135.
44. Witvrouw M., De Clercq E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol. 1997, 29:497-511.